Supernus Pharmaceuticals | SUPN - Market Capitalization


Supernus Pharmaceuticals reported $2.76B in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 217.86B 15.25B Dec/2025
ANI Pharmaceuticals USD 1.77B 269M Dec/2025
Aurora Cannabis CAD 327.21M 142.93M Dec/2025
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Canopy Growth CAD 656.46M 124.89M Dec/2025
Cara Therapeutics USD 366M 338M Sep/2025
Corcept Therapeutics USD 3.66B 5.1B Dec/2025
Eisai JPY 1.31T 140.95B Dec/2025
Eli Lilly USD 1.02T 293.84B Dec/2025
Novo Nordisk A/S DKK 1.45T 86.62B Dec/2025
Pacira USD 1.06B 94M Dec/2025
Perrigo USD 1.92B 1.04B Dec/2025
Pfizer USD 141.57B 6.48B Dec/2025
Supernus Pharmaceuticals USD 2.85B 151M Dec/2025
United Therapeutics USD 20.98B 2.02B Dec/2025
Xeris Pharmaceuticals USD 1.3B 12M Dec/2025